Global Innovative Platforms Inc. (GIPL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US37960M1018
Global Innovative Platforms Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -718,251.00 USD |
| EBIT | -718,251.00 USD |
| Net income | -718,251.00 USD |
| Diluted EPS – continuing operations | -0.02 USD |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Global Innovative Platforms Inc.
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
More stocks
- Traws Pharma, Inc. (TRAW)
- Liminatus Pharma, Inc. (LIMN)
- OLB GROUP, INC. (OLB)
- SUIC Worldwide Holdings Ltd. (SUIC)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
- Perfect Moment Ltd. (PMNT)
- GHST World Inc. (GHST)
- International Land Alliance Inc. (ILAL)
- Cyngn Inc. (CYN)
- Trevi Finanziaria Industriale SpA (TFIN.MI)
- Imunon, Inc. (IMNN)
- Sports Entertainment Gaming Global Corp (SEGG)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.